A new generation of innovative receptor targeted drugs rapidly enters the market. However, since these drugs target a specific receptor, they are not of value for all cancer patients, but only for specific tumor types or a subset within a tumor type. This makes it increasingly important to select the patients that might benefit from the targeted therapy and offers a potential role for receptor imaging wih radiolabeled variants of these drugs. ... Zie: Summary
Originele taal-2English
KwalificatieDoctor of Philosophy
  • de Vries, Liesbeth, Supervisor
Datum van toekenning3-jan-0001
Plaats van publicatieGroningen
Gedrukte ISBN's9789090204147, 9090204148
StatusPublished - 2006

Citeer dit